title: Moving the needle: Optimizing classification for glioma.
abstract: Genomic markers provide unbiased information that is increasingly being used to enhance traditional histopathology approaches for classification of cancer samples.
authors.affiliation: Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. rverhaak@mdanderson.org.
authors.forename: Roel G W
authors.initials: RG
authors.lastname: Verhaak
mesh_terms: D001254:Astrocytoma / Q000145:classification / Q000175:diagnosis; D014408:Biomarkers, Tumor / Q000378:metabolism; D001932:Brain Neoplasms / Q000145:classification / Q000175:diagnosis; D005909:Glioblastoma / Q000145:classification / Q000175:diagnosis; D005910:Glioma / Q000145:classification* / Q000175:diagnosis*; D006801:Humans; D009837:Oligodendroglioma / Q000145:classification / Q000175:diagnosis
chemical_list: D014408:Biomarkers, Tumor